Within the circulatory system, blood flow regulates vascular remodelling 1 , stimulates blood stem cell formation 2 , and has a role in the pathology of vascular disease 3 . During vertebrate embryogenesis, vascular patterning is initially guided by conserved genetic pathways that act before circulation 4 . Subsequently, endothelial cells must incorporate the mechanosensory stimulus of blood flow with these early signals to shape the embryonic vascular system 4 . However, few details are known about how these signals are integrated during development. To investigate this process, we focused on the aortic arch (AA) blood vessels, which are known to remodel in response to blood flow 1 . By using twophoton imaging of live zebrafish embryos, we observe that flow is essential for angiogenesis during AA development. We further find that angiogenic sprouting of AA vessels requires a flowinduced genetic pathway in which the mechano-sensitive zinc finger transcription factor klf2a 5-7 induces expression of an endothelial-specific microRNA, mir-126, to activate Vegf signalling. Taken together, our work describes a novel genetic mechanism in which a microRNA facilitates integration of a physiological stimulus with growth factor signalling in endothelial cells to guide angiogenesis.
Within a blood vessel, flow exerts tangential and perpendicular forces on endothelial cells, leading to cytoskeletal rearrangements and changes in gene expression 4 . Whereas initial embryonic vascular patterning is largely independent of these haemodynamic forces, the onset of circulation drives subsequent remodelling of the circulatory system 4 . For example, flow has an important role in the unilateral regression of the sixth AA during mouse development 1 . In zebrafish, the fifth and sixth AA arise after flow begins and form a persistent connection to the lateral dorsal aortae (LDA) that provides circulation to the trunk 8, 9 . These vessels continue to undergo angiogenesis throughout larval stages to comprise the gill vasculature 9 . To investigate how flow affects angiogenesis, we observed development of AA5 and 6 in zebrafish embryos by two-photon time-lapse imaging (Supplementary Fig. 1a -c). To covisualize endothelial cells and flow, we performed microangiography on Tg(kdrl:egfp) la116 embryos, which display fluorescent green endothelial cells, using unconjugated quantum dots (QDots). At 46 h post fertilization (h.p.f.), we observed AA perfusion, but no connection between the fifth and sixth AA and the LDA (data not shown and Supplementary Fig. 1d , 46 h.p.f.). Several hours later, the AA5/6 connecting vessel (referred to as AA5x according to ref. 8) sprouted from the left and right AAs (Supplementary Movie 1). At this point, the sprouts were sufficiently lumenized to allow perfusion with QDots ( Supplementary  Fig. 1d , 53.75 h.p.f., magnified 34; Supplementary Movies 1 and 2). However, blood cells entering from the ventral aorta (VA) became trapped in AA5 and 6 (Supplementary Movie 3). AA5x sprouts then fused with the LDA to form a patent circulatory connection ( Supplementary Fig. 1d , 59.75 h.p.f., Supplementary Movie 1). Subsequently, the AA5x fully lumenized and blood flow through AA5 and 6 commenced (Supplementary Movie 4). These observations indicated that the AA5x develops via concomitant angiogenesis and lumenization in the presence of flow.
To determine if flow was required for this process, we performed unilateral laser microsurgery on Tg(kdrl:egfp) la116 embryos to sever the connection between the VA and AA5 and 6 before AA5x sprouting ( Supplementary Figs 1e and 2a ). Following microsurgery at 46 h.p.f., we observed normal AA perfusion on the unoperated side by microangiography at 72 h.p.f. (Fig. 1a ). By contrast, on the operated side (right) AA5 and 6 failed to bear flow ( Fig. 1b ), although cranial blood vessels and the AAs seemed morphologically normal ( Fig. 1b and Supplementary Fig. 2b) . A dorsal view of the same embryo showed that the AA5x formed on the left side of the embryo, but not on the right side where flow was blocked ( Fig. 1c and Supplementary  Table 1 ). To support these results, we treated Tg(kdrl:egfp) la116 embryos beginning at 46 h.p.f. with the myosin ATPase inhibitor 2,3-butanedione 2-monoxime (BDM) or the anaesthetic tricaine methanesulphonate to arrest the heart and block circulation 10 . In both treatments, embryos failed to form the AA5x (Fig. 1d , e and Supplementary Table 1 ), although vascular morphogenesis in other anatomical locations seemed normal ( Supplementary Fig. 3 ). Twophoton time-lapse microscopy of embryos without flow indicated that a failure to initiate sprouting, rather than vessel regression, was responsible for loss of AA5x (Supplementary Movies 5 and 6). Time-lapse analysis using Tg(fli1a:negfp) y7 embryos, in which endothelial cell nuclei are labelled with EGFP (enhanced green fluorescent protein), showed decreased migratory activity of cells within the aortic arches in the absence of flow when compared to wild type (Supplementary Movies 7 and 8). Interestingly, embryos injected with a gata1 morpholino displayed normal AA5x development ( Fig. 1f and Supplementary Table 1 ), indicating that shear stress from blood cells was dispensable for AA5x angiogenesis. Together, these results indicate that the AA5x forms via angiogenesis and that this process is dependent on flow.
Vascular endothelial growth factor (Vegf) signalling has been implicated in flow-mediated AA remodelling in mouse embryos 1 . Accordingly, we observed AA expression of the zebrafish Vegf receptor-2 orthologue, kdrl, including expression in the developing AA5x at 48 h.p.f. ( Supplementary Fig. 4a ). We also observed vegfa expression in the developing glomerulus ( Supplementary Fig. 4b, c ), which is located near the branch point of the dorsal aorta and towards which the AA5x sprouts ( Supplementary Fig. 4d ), and in cells surrounding the AA blood vessels ( Supplementary Fig. 4e ). Consistent with a role for Vegf signalling during AA5x angiogenesis, embryos bearing a kinase-dead mutation in Kdrl (referred to as kdrl y17 ; ref. 11) failed to form a patent AA5x ( Fig. 1g ; Supplementary Table 1 ). Furthermore, treatment with the Vegf receptor inhibitor SU5416 from 46 to 65 h.p.f. resulted in a block in AA5x formation, whereas DMSO (dimethylsulphoxide) had no effect (Fig. 1h , i and Supplementary Table 1 ). Similarly, partial reduction of Vegfa using a low morpholino dose (3 ng; see ref. 12 ) blocked AA5x development ( Fig. 1j , k). Overall vascular morphology and circulatory function, including initial perfusion of the aortic arches, were normal following these manipulations ( Supplementary Fig. 3 ). These observations demonstrate that AA5x formation requires Vegf signalling. In other developmental settings, Notch signalling coordinates Vegf-stimulated angiogenesis 13, 14 . However, we did not detect expression of Notch signalling molecules or Notch activation in the AAs ( Supplementary  Fig. 5a -c) and AA5x was not affected by loss of the Notch ligand dll4 ( Supplementary Fig. 5d ). These results indicate that a Notchindependent mechanism is responsible for Vegf-stimulated AA5x angiogenesis.
A possible candidate gene responsible for integrating flow and Vegf signalling during AA5x formation was the zinc finger transcription factor, klf2, which is induced by flow in endothelial cells 6, 7 . We observed that zebrafish klf2a was expressed in the AA in a pattern similar to the endothelial marker cadherin 5 (cdh5, also known as vascular endothelial cadherin; Fig. 2a ) and was expressed in the developing AA5x ( Supplementary Fig. 4f ). Furthermore, AA expression of klf2a, but not cdh5, was reduced in cardiac troponin T2 (tnnt2)deficient embryos, which lack circulation ( Fig. 2a , Supplementary  Table 2 and Supplementary Fig. 6a , ref. 15 ) and in embryos treated with tricaine ( Supplementary Fig. 6b and Supplementary Table 2 ). To determine if klf2a was required for AA5x angiogenesis, we used morpholinos targeting either the klf2a exon 3 splice acceptor site (Supplementary Fig. 7a , b) or the klf2a start codon. Embryos injected with either morpholino displayed normal morphology and grossly normal circulatory patterns, including perfusion of the aortic arches following angiography ( Supplementary Fig. 7c, d and data not shown), consistent with recent work demonstrating relatively normal flow patterns and heart rate in klf2a-deficient zebrafish embryos at 48 h.p.f. 16 . However, the normal transient AA circulatory block persisted in klf2a-deficient embryos (compare Supplementary Movies 3, 4 and 9), indicating a defect in AA5x formation. Indeed, whereas embryos injected with control morpholino seemed normal, klf2a-deficient siblings failed to develop the AA5x (Fig. 2b, Supplementary Fig. 7e , f and Supplementary Table 3 ). Thus, despite the presence of flow, loss of klf2a mimics the AA5x defect observed in embryos lacking flow or Vegf signalling.
In Xenopus laevis embryos, klf2 is important for Vegf receptor-2 expression 17 zebrafish embryos ( Supplementary Fig. 6a, c) . Similarly, neither kdrl nor vegfa were altered in embryos lacking circulation ( Supplementary  Fig. 6a , c) and we did not observe consistent reduction in other known klf2 responsive genes [5] [6] [7] in the absence of flow or klf2a ( Supplementary  Fig. 6a ). These results raised the possibility that a post-transcriptional mechanism linked flow, klf2a and Vegf signalling. A candidate for this role was the endothelial-restricted microRNA, miR-126 (ref. 18 ), which can enhance Vegf signalling 19, 20 . Whereas miR-126 expression was apparent in the embryonic vasculature before circulation (Supplementary Fig. 8a) , at later stages its expression seemed much higher in the AAs (Fig. 3a, Supplementary Fig. 8a ). Strikingly, we found that AA miR-126 expression was dependent on both flow and klf2a expression. Whereas control embryos expressed high levels of miR-126 within the AAs, tnnt2-or klf2a-deficient embryos did not ( Fig. 3a-c , Supplementary Figs 6a and 8b , and Supplementary Table 2 ). By contrast, expression of cdh5 and let-7a was unchanged in the absence of flow or klf2a (Fig. 3d-f and Supplementary Fig. 8b ), ruling out a general defect in endothelial gene expression or microRNA processing, respectively. Tricaine treatment to block flow similarly reduced miR-126 AA expression ( Supplementary Fig. 6b and Supplementary  Table 2 ). Embryos injected with a morpholino to prevent miR-126 processing (Supplemental Fig. 8c ) displayed blocked AA circulation (Supplementary Movie 10) and haemorrhage in this region by 60 h.p.f. (Supplementary Fig. 8d ). Similar to loss of klf2a, the AA5x did not form in miR-126-deficient embryos (Fig. 3g , Supplementary  Table 3 and Supplementary Movie 11). We also observed ectopic branching of segmental vessels and abnormal patterning of cranial blood vessels in miR-126-deficient embryos ( Supplementary Fig. 8e ). These results demonstrate that AA expression of miR-126 requires flow and klf2a and that miR-126 itself is required for AA5x angiogenesis.
Our results indicated that klf2a acted upstream of miR-126 to induce flow-stimulated angiogenesis. Consistent with this possibility, exogenous klf2a in embryos lacking blood flow restored AA miR-126 expression ( Supplementary Fig. 9a-c) . To test their genetic interaction further, we co-injected klf2a and miR-126 morpholinos at suboptimal doses that individually caused no or mild low penetrant aortic arch defects ( Fig. 3h , i, Supplementary Fig. 9d , e, and Supplementary Table 3 ). Co-injection of both morpholinos in this case caused a drastic increase in the penetrance of AA5x defects, indicating that miR-126 and klf2a act in a common pathway (Fig. 3j , Supplementary Fig. 9e and Supplementary Table 3 ). Interestingly, other vascular defects observed in miR-126-deficient embryos were not apparent in co-injected embryos ( Supplementary Fig. 8e , data not shown), indicating a specific genetic interaction between miR-126 and klf2a during AA5x development. To confirm further that miR-126 functioned downstream of klf2a, we drove mosaic endothelial expression of a miR-126/monomeric cherry (mcherry) transgene in klf2a-deficient embryos using the fli1ep promoter fragment (Supplementary Fig. 10a; ref. 21 ). This construct drove flow-independent endothelial expression of mature miR-126 ( Supplementary Fig. 10b , c and data not shown) and led to an increased proportion of klf2adeficient embryos with AA5x formation as compared to injection of klf2a morpholino alone ( Supplementary Table 3 ). Rescued embryos displayed miR-126/mcherry transgene expression in AA5x endothelial cells, including cases of bi-and unilateral rescue (Fig. 3k, l) , whereas the control fli1ep:mcherry transgene failed to rescue (Fig. 3m) . These results indicate that miR-126 acts downstream of klf2a to drive flow-stimulated angiogenesis.
miR-126 promotes angiogenesis by repressing spred1 and pik3r2, which normally inhibit Vegf signalling 19, 20 . Our observations indicated that in the absence of flow and klf2a, reduced miR-126 expression allows upregulation of these genes, thereby preventing Vegf-induced AA5x angiogenesis. Although miR-126 can repress the zebrafish spred1 39 untranslated region (UTR), it had no effect on pik3r2 in whole-embryo miRNA sensor assays ( Supplementary Fig. 11a ). Using an endothelial autonomous miRNA sensor assay ( Supplementary Fig. 11b ), we further found that the spred1 39UTR prevented expression of a mcherry transcript in blood vessels, whereas egfp fused to a control 39UTR was expressed (Fig. 4a, b and Supplementary Fig. 11c ). By contrast, the mcherry-spred1-39UTR transgene was robustly expressed in embryos lacking miR-126, blood flow, or klf2a (Fig. 4c-h and Supplementary  Fig. 11c ). These results support a genetic pathway in which spred1 repression is mediated by klf2a and miR-126 in response to flow. Accordingly, overexpression of mRNA encoding Spred1 blocked AA5x formation (Fig. 4i, j and Supplementary Table 3 ), whereas reducing Spred1 in miR-126-deficient embryos rescued AA5x development (Fig. 4k, l and Supplementary Table 3 ). Taken together, our findings support the existence of a genetic pathway in which flow induces klf2a and miR-126 (Fig. 4m) . Although our data show that the interaction between these genes occurs in AA endothelial cells, we cannot rule out the possibility of an indirect role for klf2a upstream of miR-126. Nevertheless, flow-stimulated miR-126 subsequently inhibits spred1 in endothelial cells to allow angiogenesis to proceed in response to Vegf (Fig. 4m ). In the absence of flow, klf2a and miR-126 levels are reduced, allowing spred1 to repress Vegf-stimulated angiogenesis. Thus, miR-126 provides a crucial link between flow and Vegf signalling to promote angiogenesis. Importantly, flow, klf2a and miR-126 were similarly required for angiogenesis in the zebrafish-xenograft model 22 ( Supplementary Fig. 12 ), indicating that this pathway may represent a general mechanism for flow-stimulated angiogenesis in the zebrafish. The stereotyped pattern of the vertebrate circulatory system is initially established by conserved genetic pathways that act before circulation to drive endothelial differentiation and provide guidance cues. How haemodynamic forces subsequently modulate these pathways in vivo is largely unknown. Our current work provides new insights into how an endothelial cell's response to flow can be integrated with early developmental signals to drive angiogenesis in the presence of flow.
METHODS SUMMARY
Zebrafish and their embryos were handled according to standard protocols 23 and in accordance with University of Massachusetts Medical School IACUC guidelines. For laser-assisted microsurgery, embryos at 46 h.p.f. were anaesthetized and immobilized in 0.5% of low-melt agarose (Bio-Rad). The connection between AA5 and AA6 and the ventral aorta was ablated using a Micropoint laser (Photonic Instrument) mounted on a Zeiss AX10 Imager M1. SU5416 (Calbiochem) was prepared and used as described previously 11 . Control embryos were treated with 0.1% DMSO. To arrest heartbeat, embryos were treated with 15 mM of 2,3-butanedione 2-monoxime (BDM; Sigma-Aldrich) or with buffered Tricaine methanesulphonate (Sigma-Aldrich) at 0.66 mg ml 21 in egg water for the indicated times. Two-photon time-lapse imaging, confocal microscopy and microangiography was performed as previously described 13, 24 , with additional modifications as noted in Methods. Antisense riboprobes against dll4, vegfa, kdrl, fli1a and cdh5 were generated and used for whole mount in situ hybridization as described elsewhere 25 . A klf2a fragment was PCR-amplified and cloned by Gateway recombination. The resulting clone was linearized with BglII and a DIG-labelled riboprobe was synthesized using T7 polymerase.
Digoxigenin (DIG)-labelled locked nucleic acid (LNA) probes (Exiqon, Copenhagen) were used to detect mature miR-126 and let-7 using in situ hybridization or Northern analysis as described elsewhere 18 . Morpholinos (Gene-Tools), mRNA and Tol2-based plasmids were prepared and injected as previously 11, 21 . In cases of co-injection with morpholinos, Tol2-plasmids and transposase, a DNA/transposase mRNA mixture was initially injected, followed by morpholino. Plasmid construction details are provided in the full Methods section. Morpholinos against vegfa, tnnt2 and gata1 have been described elsewhere 15, 25, 26 ; all other Morpholino and oligonucleotide sequences are provided in Methods.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
Supplementary
Information is linked to the online version of the paper at www.nature.com/nature. LETTERS METHODS Zebrafish lines. The Tg(kdrl:egfp) la116 and kdrl y17 lines have been described elsewhere 8, 11 . The Notch sensor line, Tg(tp1bglob:egfp) um14 , has been described and validated as Notch-responsive in previous studies 27 . A description of the Tg(fli1ep:dsRedEx) um13 line can be found in ref. 28 and the Tg(fli1a:negfp) y7 line is described in ref. 29 . Two-photon time-lapse imaging and confocal microscopy. Embryos were treated with 0.003% 1-phenyl-2-thiourea (PTU) to prevent pigmentation and immobilized using 0.1% tricaine as described elsewhere 13 . Microangiography was performed using Qtracker 655 non-targeted quantum dots (Invitrogen) or rhodamine-labelled dextran as described elsewhere 13 . Embryos were mounted in low-melt agarose containing PTU and Tricaine as previously described 13 . Two-photon imaging was performed as previously 24 , except that GFP and unconjugated Qdots (655 nm emission) were simultaneously excited at 830 nm and the emitted fluorescence separated using a two-photon specific filter cube with 510/50 nm and 645/60 nm emission bandpasses. Both the sample and the objective were kept at 28 uC during the experiment. Laser scanning confocal microscopy was performed as described elsewhere 11 . To generate time-lapse movies and vertical projections, we used Imaris (Bitplane). Flash Professional 8 (Macromedia) was used to label movies. Transgenic miRNA expression construct. To create a vector capable of expressing a zebrafish mature miRNA in a cell-type-specific manner, we relied on multisite Gateway cloning. For the miRNA cassette, we constructed a middle entry (pME) clone containing a 753 bp fragment of the zebrafish EF1alpha gene (also known as ef1a, accession number NM_131263) encompassing the TATA box, first non-coding exon 1, intron 1 and partial exon 2, 59 of the ATG. This fragment was PCR-amplified from genomic zebrafish DNA using high fidelity DNA polymerase (forward 59-CGCTCGGTCCTCCTCTCGAGTATAAATT CTC-39 and reverse 59-CTTTCCCATGTCGACTAAGTTTCTGCGGACC-39), cloned into a TOPO TA cloning vector (Invitrogen) and validated by sequencing. A multicloning site was inserted between the StuI and ClaI restriction sites of intron 1 by annealing the primers 59-CCTCTGTGGTACCATTCTACATGT GTTGATTTTCTGTATTTTAGTGAATTCTGTGAT-39 and 59-CGATCACAGAA TTCACTAAAATACAGAAAATCAACACATGTAGAATGGTACCACAGAGG-39 to allow insertion of a pri-miRNA with KpnI and EcoRI restriction sites. Finally, the recombinant fragment was shuttled into pDONR 221 (Invitrogen) by first amplifying the insert using the primers 59-GGGACAAGTTTGTACAAAAAAGCAGG CTCTCGAGTATAAATTCTCCAACCAAAGC-39 (forward) and 59-GGGGACC ACTTTGTACAAGAAAGCTGGGTCGATACCGTCGACTAAGTTTCTGCGGA CC-39 (reverse). The resulting PCR fragment was used in a BP reaction with pDONR221 to generate a miRNA middle entry vector (pME-miR) and confirmed by sequencing.
To generate a miR-126 middle entry cassette, 600 bp of genomic sequence flanking the mature miR-126 sequence on chromosome 8 (miRBase accession number MI0001979, Zv8) was amplified by PCR (see below for primer sequences). The resulting fragment was cloned by Zero Blunt TOPO PCR Cloning (Invitrogen) and validated by sequencing. The miR-126 fragment was subcloned using flanking EcoRI sites into pME-miR to give pME-miR126 (see above). To generate an endothelial autonomous miRNA expression construct, we used multisite Gateway LR cloning. The following plasmids were included in the multisite reaction: p5E-fli1ep 28 , pME-miR-126, p3E-mcherry 21, 30 , and pDestTol2pA 30 . A control vector was constructed by using the empty pME-miR in a parallel LR multisite reaction. The reaction was performed using LR clonase II plus (Invitrogen) as previously described 21 . miRNA sensor assays. We amplified the 39UTR of zebrafish spred1 or pik3r2 by PCR and cloned them via BP Gateway recombination with pDONR P2-P3 (Invitrogen) to generate 39 entry plasmids (p3E-spred1-39utr, p3E-pik3r2-39utr, see later for primer sequences). For whole-embryo assays, we generated a pCS2-based construct by performing multisite Gateway LR reactions with pCS2Dest2 (ref. 21) , pENTR-egfp (ref. 21 ) and the p3E-spred1-39utr or p3E-pik3r2-39utr entry clones. The resulting plasmids were referred to as pCS-egfp-spred1-39utr or pCS-egfp-pik3r2-39utr. These plasmids were linearized by digestion with NotI and used as templates to synthesize capped mRNA using SP6 polymerase (mMessage Machine, Ambion). As a control, we synthesized mRNA encoding the monomeric red fluorescent protein, mcherry, containing the SV40 late polyadenylation sequence found in pCS2. mcherry mRNA (60 pg) was coinjected with 60 pg of egfp sensor mRNA with or without 60 fmol of miR-126 duplex (see below for sequences) into one-cell stage zebrafish embryos. Embryos were observed at 24 h.p.f. for mCherry and EGFP expression using a MZFLIII microscope equipped with epifluorescence. Digital images were captured using a Zeiss mRC digital camera and AxioVision software.
To generate an endothelial autonomous miRNA sensor construct, we cloned the basal promoter-EGFP-polyA cassette from plasmid pENTRbasEGFP 21 into
